DERM vs TMO · rev $56.1M vs P/E 24, rev $44.56B
Journey Medical Corp (DERM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
DERM currently screens at market cap $163.1M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the DERM and TMO stock pages for the full models.
Not investment advice.